Evidence map›Paper›PMID 36536048›Full record

ArticleBritish journal of cancer2023

Response to: Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis (BJC-LT3342090).

Harry D Green, Samuel W D Merriel, Richard A Oram, Katherine S Ruth, Jessica Tyrrell, Samuel E Jones, Chrissie Thirlwell, Michael N Weedon, Sarah E R Bailey

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Harry D GreenExeter Centre of Excellence for Diabetes Research (EXCEED), University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
Samuel W D MerrielDISCOVERY Group, University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.ORCID http://orcid.org/0000-0003-2919-9087
Richard A OramInstitute of Biomedical and Clinical Science, University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
Katherine S RuthGenetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, EX2 5DW, UK.
Jessica TyrrellGenetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, EX2 5DW, UK.
Samuel E JonesInstitute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland.
Chrissie ThirlwellUniversity of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
Michael N WeedonInstitute of Biomedical and Clinical Science, University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
Sarah E R BaileyDISCOVERY Group, University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK. s.e.r.bailey@exeter.ac.uk.ORCID http://orcid.org/0000-0003-0020-4778

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

OverdiagnosisProstatic NeoplasmsEarly Detection of CancerHumansMaleMass ScreeningMedical OveruseProstate-Specific AntigenRisk FactorsProstate-Specific Antigen

Identifiers

PMID36536048
PMCPMC9938192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.